Juntendo University, Tokyo, established in 1838.

  1. Home
  2. Research
  3. Department of Nephrology

Department of Nephrology

 Introduction   Staff   Research   Education   Achievements
 Japanese     Index

Achievements　（2013）

｜2014｜2013｜2012｜
  1. Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial. Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Shuto H, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y; The Refractory Nephrotic Syndrome Study Group. Clin Exp Nephrol. 2013
  2. Disruption of Smad4 expression in T cells leads to IgA nephropathy-like manifestations. Inoshita H, Kim BG, Yamashita M, Choi SH, Tomino Y, Letterio JJ, Emancipator SN. PLoS One. 2013 ;8:e78736
  3. A case of arteriovenous fistula after renal biopsy in an IgA nephropathy patient with macroscopic hematuria. Horikoshi S, Takahata A, Shiraishi A, Fukuda H, Ohsawa I, Kuwatsuru R, Tomino Y. Case Rep Nephrol Urol. 2013 ;3:64-8
  4. Renoprotective effects of the L-/T-type calcium channel blocker benidipine in patients with hypertension. Tomino Y. Curr Hypertens Rev. 2013 ;9:108-14
  5. Amelioration of angiotensin II-induced salt-sensitive hypertension by liver-type fatty acid-binding protein in proximal tubules. Osaki K, Suzuki Y, Sugaya T, Tanifuji C, Nishiyama A, Horikoshi S, Tomino Y. Hypertension. 2013 ;62:712-8
  6. Transperitoneal calcium balance in anuric continuous ambulatory peritoneal dialysis and automated peritoneal dialysis patients. Hamada C, Tomino Y. Int J Nephrol. 2013 ;2013:863791
  7. Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema. Ohsawa I, Nagamachi S, Suzuki H, Honda D, Sato N, Ohi H, Horikoshi S, Tomino Y. BMC Gastroenterol. 2013 ;13:123
  8. Association of the cardioankle vascular index and ankle-brachial index with carotid artery intima media thickness in hemodialysis patients. Gohda T, Gotoh H, Gotoh Y, Yamaguchi S, Tomino Y. Int J Nephrol. 2013 ;2013:401525
  9. Usefulness of HPLC assay for early detection of microalbuminuria in chronic kidney disease. Horikoshi S, Okuda M, Nishimura E, Ohsawa I, Suzuki Y, Shimizu Y, Hamada C, Tomino Y. J Clin Lab Anal. 2013 ;27:333-8
  10. Effect of the Direct Renin Inhibitor Aliskiren on Urinary Albumin Excretion in Spontaneous Type 2 Diabetic KK-A (y) Mouse. Furukawa M, Gohda T, Hagiwara S, Tanimoto M, Horikoshi S, Funabiki K, Tomino Y. Int J Nephrol. 2013 ;2013:519130
  11. Distribution of dimethylarginine-dimethylaminohydrolase-II (DDAH2) gene polymorphism in hemodialysis patients. Thaha M, Yusuf M, Empitu MA, Bakarman A, Tomino Y. Acta Med Indones. 2013 ;45:83-8
  12. Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy. Furukawa M, Gohda T, Tanimoto M, Tomino Y. ScientificWorldJournal. 2013 ;2013:928197
  13. Immunopathological predictors of prognosis in IgA nephropathy. Tomino Y. Contrib Nephrol. 2013 ;181:65-74
  14. Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy. Suzuki H, Ohsawa I, Kodama F, Nakayama K, Ohtani A, Onda K, Nagamachi S, Kurusu A, Suzuki Y, Ohi H, Horikoshi S, Tomino Y. J Nephrol. 2013 ;26:708-15
  15. Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors. Gohda T, Tomino Y. Curr Diab Rep. 2013 ;13:560-6
  16. Nationwide survey on current treatments for IgA nephropathy in Japan. Matsuzaki K, Suzuki Y, Nakata J, Sakamoto N, Horikoshi S, Kawamura T, Matsuo S, Tomino Y. Clin Exp Nephrol. 2013 ;17:827-33
  17. Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010. Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Kawamura T, Takeda T, Hataya H, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Shimizu A, et al. Clin Exp Nephrol. 2013 ;17:155-73
  18. Usefulness of change in estimated glomerular filtration rate as a predicting factor of progression of chronic kidney disease. Maeda K, Hamada C, Horikoshi S, Tomino Y. ISRN Nephrol. 2013 ;2013:351364
  19. Translocation of dendrin to the podocyte nucleus in acute glomerular injury in patients with IgA nephropathy. Kodama F, Asanuma K, Takagi M, Hidaka T, Asanuma E, Fukuda H, Seki T, Takeda Y, Hosoe-Nagai Y, Asao R, Horikoshi S, Tomino Y. Nephrol Dial Transplant. 2013 ;28:1762-72
  20. Experimental evidence of cell dissemination playing a role in pathogenesis of IgA nephropathy in multiple lymphoid organs. Nakata J, Suzuki Y, Suzuki H, Sato D, Kano T, Horikoshi S, Novak J, Tomino Y. Nephrol Dial Transplant. 2013 ;28:320-6
  21. Predictive factors associated with change rates of LV hypertrophy and renal dysfunction in CKD patients. Okumura K, Io H, Matsumoto M, Seto T, Takagi M, Masuda A, Furukawa M, Nagahama L, Omote K, Hisada A, Hamada C, Horikoshi S, Tomino Y. Clin Nephrol. 2013 ;79:7-14
  22. Pentraxin 3 as a new biomarker of peritoneal injury in peritoneal dialysis patients. Kanda R, Hamada C, Kaneko K, Nakano T, Wakabayashi K, Io H, Horikoshi S, Tomino Y. J Artif Organs. 2013 ;16:66-73
  23. GFR estimation using standardized serum cystatin C in Japan. Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S; Collaborators Developing the Japanese Equation for Estimated GFR. Am J Kidney Dis. 2013 ;61:197-203
  24. Extraglomerular C3 deposition and metabolic impacts in patients with IgA nephropathy. Ohsawa I, Kusaba G, Ishii M, Sato N, Inoshita H, Onda K, Hashimoto A, Nagamachi S, Suzuki H, Shimamoto M, Ohi H, Horikoshi S, Tomino Y. Nephrol Dial Transplant. 2013 ;28:1856-64
  25. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease. Kawamura T, Joh K, Okonogi H, Koike K, Utsunomiya Y, Miyazaki Y, Matsushima M, Yoshimura M, Horikoshi S, Suzuki Y, Furusu A, Yasuda T, Shirai S, Shibata T, Endoh M, Hattori M, Katafuchi R, Hashiguchi A, Kimura K, Matsuo S, Tomino Y; Study Group Special IgA Nephropathy. J Nephrol. 2013 ;26:350-7
  26. Acceleration of crescent formation by L1 retrotransposon in mouse BSA-induced nephritis. Mugitani N, Shimizu Y, Satake K, Suzuki Y, Horikoshi S, Tomino Y. J Nephrol. 2013 ;26:375-84
 Introduction   Staff   Research   Education   Achievements
 Japanese     Index
To Page Top